Abstract
We investigated the effects of tumor necrosis factor (TNF) α, interferon (IFN) ψ and interleukin-2 (IL-2) on themdr1 gene expression in four human colon carcinoma cell lines (LoVo, HT 115, SW 480, and LS 174T) at different times (8. 24, 48, and 72h). We found no significant changes inmdr1 expression after 8h and 24h of cytokine treatment in all four lines. After 48h and 72h, however, a marked reduction ofmdr1 expression in LoVo, HT 115, and SW 480 cells and an unaffected expression in LS 174T cells was observed. We examined whether the cytokine-mediated reduction ofmdr1 expression correlates to the multidrug resistance (MDR) phenotype. In those cell lines showing a decreasedmdr1 expression after a long-term cytokine pretreatment we found a dramatic enhancement of cytotoxicity of the MDR relevant drugs vincristine and doxorubicin, whereas LS 174T cells remained resistant. By contrast, the simultaneous application of cytokines and cytostatics caused no additive or synergistic effects. We conclude that in certain colon carcinoma cell lines a decreasedmdr1 expression caused by prolonged cytokine pretreatment correlates with an enhanced cytotoxicity of drugs susceptible to MDR as an MDR-overcoming effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- MDR:
-
multidrug resistance
- TNFα:
-
tumor necrosis factor α
- IFNψ:
-
interferon ψ
- IL-2:
-
interleukin-2
- Vin:
-
vincristine
- Dox:
-
doxorubicin
- IC50 :
-
inhibition concentration
References
Ashall F, Bramwell ME, Harris H (1982) A new marker for human cancer cells. 1. The Ca antigen and the Ca 1 antibody. Lancet II:1–6
Biedler JE (1993) Genetic aspects of multidrug resistance. Cancer 70:1799–1809
Carnichael J, Debraff WG, Gazdar AF (1987) Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity. Cancer Res 47:936–942
Chapekar MS, Huggett A, Chung C (1991) Dexamethasone prevents the growth inhibitory effects of recombinant tumor necrosis factor in a rat hepatoma cell line Reuber-RC-3: an association with changes in the messenger RNA levels for multidrug resistance gene. Biochem Biophys Res Commun 181:1524–1531
Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transporter proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381–389
Chin K-V, Ueda K, Pastan I, Gottesman MM (1992) Modulation and activity of the promoter of the human mdr1 gene by Ras and p53. Science 255:459–462
Chin K-V, Pastan I, Gottesman MM (1993) Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157–180
Dimanche-Boitrel M-T, Pelletier H, Genne P, Petit J-M, Le Grimellec Ch, Canal P, Ardiet C, Bastian G, Chauffert B (1992) Confluence dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. Int J Cancer 50:677–682
Drewinko B, Romsdahl MM, Yang LY, Ahearn MJ, Trujillo JM (1976) Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 36:467–475
Evans CH, Baker PD (1992) Decreased P-glycoprotein expression in multidrug-sensitive and-resistant human myeloma cells induced by the cytokine leukoregulin. Cancer Res 52:5893–5899
Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265–269
Germann UA, Pastan I, Gottesman MM (1993) P-glycoproteins: mediators of multidrug resistance. Semin Cell Biol 4:63–76
Hamada H, Tsuruo T (1991) Growth inhibition of multidrug-resistant cells by monoclonal antibodies against P-glycoprotein. In: Roninson IB (ed) Molecular and cellular biology of multidrug resistance in tumor cells. Plenum, New York, pp 373–391
Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, Tanigushi T (1991) Interaction of the IL-2 receptor with the sre-family kinase p56lck: identification of novel intermolecular association. Science 252:1523–1528
Herzog CE, Tsokos M, Bates SE, Fojo AT (1993) Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268:2946–2952
Hofsli F, Nissen-Meyer J (1990) Reversal of multidrug resistance by lipophilic drugs. Cancer Res 50:3997–4002
Juranka PF, Zastawny RL, Ling V (1989) P-glycoprotein: multidrug resistance and a superfamily of membrane-associated transport proteins. FASEB J 3:2583–2592
Kellen JA (1993) The reversal of multidrug resistance in cancer (review). Anticancer Res 13:959–961
Lai G-M, Chen Y-N, Mickley LA, Fojo AT, Bates SE (1991) P-glycoprotein expression and schedule dependence of Adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer 49:696–703
Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND (1976) Classification of human colorectal adenocarinoma cell lines. Cancer Res 36:4562–4569
Ling V (1992) P-glycoprotein and resistance to anticancer drugs. Cancer 69:2603–2609
Maniatis T, Fritsch EF, Sambrook J (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor NY, 7.52
Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N, Fojo AT (1989) Modulation of the expression of a multidrug resistance gene (mdr-1/Pglycoprotein) by differentiating agents. J Biol Chem 264:18031–18040
Mizoguchi T, Yamada K, Furukawa T, Hidaka K, Hitsugu T, Shimazu H, Tsuruo T, Sumizawa T, Akiyama S-I (1990) Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82:1679–1683
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65:55–63
Nooter K, Herweijer H (1991) Multidrug resistance (mdr1) genes in human cancer. Br J Cancer 63:663–669
Park J-G, Kramer BS, Lai S-L, Goldstein L-J, Gazdar AF (1990) Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82:193–198
Roninson IG (1991) Molecular and cellular biology of multidrug resistance in tumor cells. Plenum, New York
Roninson IG (1992) The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol 43:95–102
Sampson KE, Wolf CL, Abraham I (1993) Staurosporine reduces P-glycoprotein expression and modulates multidrug resistance. Cancer Lett 68:7–14
Sidhu RS, Bollon AP (1993) Tumor necrosis factor activities and cancer therapy — a perspective. Pharmacol Ther 57:79–128
Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735–7738
Thierry AR, Rahman A, Dritschilo A (1993) Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucletides. Biochem Biophys Res Commun 190:952–960
Tom B, Rutzky HLP, Jakstys MM, Oyasu R, Kaye CI, Kahan BD (1976) Human colonic adenocarcinoma cells. In vitro 12:180–191
Ueda K, Clark DP, Chen C-J, Roninson IB, Gottesman MM, Pastan I (1987) The human multidrug resistance (mdr1) gene. J Biol Chem 262:505–508
Walther W, Stein U, Uckert W (1993) Rapid method of total RNA minipreparation from eucaryotic cells. Nucl Acids Res 21:1682
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walther, W., Stein, U. Influence of cytokines onmdr1 expression in human colon carcinoma cell lines: Increased cytoxicity of MDR relevant drugs. J Cancer Res Clin Oncol 120, 471–478 (1994). https://doi.org/10.1007/BF01191800
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01191800